Hematologic Cancer

ARUP offers a comprehensive array of over 60 tests in the area of hematopathology including flow cytometry, molecular diagnostics, immunohistochemistry, cytogenetics and fluorescence in situ hybridization (FISH). Among the molecular tests currently offered are FLT-3, NPM-1, CEBPA, WT1, MPL, JAK2 (V617F), JAK2 (exon 12), IDH1/2, KIT, PML-RARA and BCR-ABL1 kinase. In addition, quantitative PCR testing is available for PML-RARA and BCR-ABL1 (p190 and p210). Extensive FISH testing, for both fresh and fixed specimens, is available to aid in the diagnosis and prognostication of numerous myeloid and lymphoid neoplasms. An expanded menu of immunohistochemical stains is offered by ARUP with “stain and return” service. Flow cytometry services including interpretation and consultation integration are also available.
  • Medical Director, Hematopathology and Special Genetics
    Dr. Agarwal is an associate professor of pathology at the University of Utah School of Medicine. She received her MD at Delhi University in India and was a postdoctoral research scholar at the University of Iowa. She served as a pathology resident, a hematopathology fellow, and a molecular genetics pathology fellow at the University of Utah School of Medicine. Dr. Agarwal is board certified in hematopathology, anatomic pathology, and clinical pathology. She is also a member of several professional societies, including the College of American Pathologists and the American Society for Clinical Pathology. Dr. Agarwal’s research interests include red-cell enzymopathies, hemoglobinopathies, and molecular hematopathology.
  • Medical Director, Hematopathology
    Dr. Bahler is an associate professor of pathology at the University of Utah School of Medicine. He is certified by the American Board of Pathology in clinical pathology, with an added qualification in hematology. Dr. Bahler received his PhD in immunology and his MD from the University of Rochester. His research interests include the role of antigen receptor stimulation in the development of lymphoid malignancies.
  • Medical Director, Immunology and Hemostasis/Thrombosis
    Dr. Heikal is an assistant professor at the University of Utah School of Medicine. She received her MD from Ain Shams University School of Medicine in Cairo and a master’s degree in clinical and chemical pathology from the Cairo University School of Medicine. Dr. Heikal completed a clinical immunology fellowship and a clinical pathology residency at the University of Utah School of Medicine and holds American Board of Pathology board certification in clinical pathology, as well as a New York State Department of Health certification in diagnostic immunology, hematology, and transplant monitoring. She is a fellow of the College of American Pathologists, and a member of the American Society of Clinical Pathology, Association of Medical Laboratory Immunologists, International Society on Thrombosis and Hemostasis, and the International Society of Laboratory Hematology.
  • Medical Director, Cytogenetics and Genomic Microarray
    Dr. Hong is an assistant professor of pathology at University of Utah School of Medicine. She received her MD at Beijing Medical University in Beijing, China, and completed a residency in internal medicine and hematology at People’s Hospital, Beijing Medical University, and a clinical cytogenetics fellowship at the University of Utah. Her academic interests include the clinical significance of cytogenetic findings in hematologic malignancies, particularly in pediatric leukemia and treatment-related leukemia.
  • Medical Director, Molecular Hematopathology
    Medical Director, Hematopathology
    Co-Scientific Director, NGS and Biocomputing
    Dr. Kelley is an associate professor in the Department of Pathology at the University of Utah. He received his MS in immunology and microbiology and his MD from Ohio State University, and completed his residency in anatomic and clinical pathology and fellowship training in hematopathology at the Cleveland Clinic. He is board certified in anatomic and clinical pathology by the American Board of Pathology, with subspecialty certification in hematology. His research interests include the identification of novel diagnostic and prognostic biomarkers in leukemia and lymphoma.
  • Medical Director, Hematopathology
    Dr. Miles is an associate professor of pathology at the University of Utah School of Medicine. He received his MD and a PhD in cell biology from the University of Nebraska and is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty certification in hematology. His research interests include biological subtypes of adult and pediatric non-Hodgkin lymphomas. Dr. Miles is a member the American Society of Hematology, the Society for Hematopathology, and the United States and Canadian Academy of Pathology.
  • CEO
    Medical Director, Hematopathology
    Co-Chief, Clinical Pathology
    Vice Chair, Pathology
    Senior Vice President, Research and Development
    Executive Director, ARUP Institute for Clinical & Experimental Pathology
    Dr. Perkins, a tenured professor at the University of Utah School of Medicine, has been with ARUP and the University of Utah for more than 20 years and has served in numerous leadership positions, including director of hematopathology, interim department chair, Co-Chief for the Clinical Pathology Division, and, for the past eight years, a member of ARUP Laboratories’ executive management team. She is board certified in anatomic pathology, with a special qualification in hematology. Dr. Perkins received her PhD in biochemistry from the University of Miami, and earned her MD and completed her pathology residency at Washington University in St. Louis and did a hematopathology fellowship at the University of Utah. She completed her hematopathology fellowship under Dr. Carl Kjeldsberg at the University of Utah and has published more than 200 peer-reviewed articles and 70 book chapters.
  • Medical Director, Hemostasis and Thrombosis Laboratory
    Dr. Rodgers is a professor of medicine and pathology at the University of Utah School of Medicine. He received his PhD in pharmacology and his MD from the Tulane University School of Medicine and is certified in internal medicine by the American Board of Internal Medicine and in hematology by the American Board of Pathology. Dr. Rodgers is the co-editor of Wintrobe’s Clinical Hematology.
  • Chief, Hematopathology
    Director, Hematopathology Fellowship Program
    Dr. Salama is professor of pathology, chief of hematopathology, and director of the Hematopathology Fellowship Program at the University of Utah School of Medicine. Dr. Salama received his MD from Cairo University and completed a hematopathology fellowship at the University of New Mexico and a surgical pathology fellowship at Stanford University. He is certified by the American Board of Pathology in anatomic pathology and hematopathology. His areas of interest span all aspects of hematopathology, including morphology, specialized studies of bone marrow and lymph node, and digital pathology.
  • Medical Director, Hemostasis/Thrombosis Laboratory
    Dr. Smock is an associate professor of pathology and associate program director of the Pathology Residency Program at the University of Utah School of Medicine. She completed her medical degree, residency, and fellowship training at the University of Utah and is board certified in anatomic and clinical pathology, as well as hematopathology. In addition to serving as medical director of the Hemostasis/Thrombosis Laboratory at ARUP, she is an active member of several professional organizations and national committees in this area. She is currently vice president of the North American Specialized Coagulation Laboratory Association (NASCOLA) and a member of the College of American Pathologists Coagulation Resource Committee and the National Comprehensive Cancer Network Clinical Practice Guidelines Panel for Cancer-Associated Venous Thromboembolic Disease. She is also an editorial board member for Research and Practice in Thrombosis and Haemostasis. Dr. Smock’s primary research interest is laboratory coagulation medicine.